These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Practical management of NSAID gastropathy in rheumatic patients. Peltier AP Scand J Rheumatol Suppl; 1989; 78():12-7; discussion 30-2. PubMed ID: 2786645 [TBL] [Abstract][Full Text] [Related]
4. The management of NSAID gastropathy. Howard JM; Le Riche NG Baillieres Clin Rheumatol; 1990 Aug; 4(2):269-91. PubMed ID: 2032300 [No Abstract] [Full Text] [Related]
6. Nonsteroidal anti-inflammatory drugs: gastropathy, deaths, and medical practice. Roth SH Ann Intern Med; 1988 Sep; 109(5):353-4. PubMed ID: 3044208 [No Abstract] [Full Text] [Related]
7. Epidemiology and economics of NSAID-induced gastropathy. Zeidler H Scand J Rheumatol Suppl; 1992; 92():3-8. PubMed ID: 1574686 [TBL] [Abstract][Full Text] [Related]
8. From peptic ulcer disease to NSAID gastropathy. An evolving nosology. Roth SH Drugs Aging; 1995 May; 6(5):358-67. PubMed ID: 7647425 [TBL] [Abstract][Full Text] [Related]
9. Complications of nonsteroidal antiiflammatory drug gastropathy and use of gastric cytoprotection: experience at a tertiary care health center. Bakowsky VS; Hanly JG J Rheumatol; 1999 Jul; 26(7):1557-63. PubMed ID: 10405945 [TBL] [Abstract][Full Text] [Related]
10. [NSAID-induced gastropathy and its prophylaxis]. Novikov VE; Kriukova NO; Krikova AV Eksp Klin Farmakol; 2008; 71(5):69-72. PubMed ID: 19093376 [TBL] [Abstract][Full Text] [Related]
11. NSAID gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal. Fries JF J Rheumatol Suppl; 1991 Mar; 28():6-10. PubMed ID: 2038014 [TBL] [Abstract][Full Text] [Related]
13. There's the forest. The object lesson of NSAID "gastropathy". Hadler NM J Rheumatol; 1990 Mar; 17(3):280-2. PubMed ID: 2110251 [No Abstract] [Full Text] [Related]
14. [NSAID-induced damage to the gastrointestinal mucosa]. Rodonezhskaia EV; Kharchenko NV Lik Sprava; 2001; (4):179-80. PubMed ID: 11692710 [TBL] [Abstract][Full Text] [Related]
15. [Adherence with proton pump inhibitor therapy, by continuously taking nonsteroidal anti-inflammatory drugs]. Pimanov SI; Makarenko EV; Dikareva EA Ter Arkh; 2015; 87(4):58-61. PubMed ID: 26087636 [TBL] [Abstract][Full Text] [Related]
16. There are the trees; the subject lesson of "NSAID gastropathy". Roth SH J Rheumatol; 1991 Apr; 18(4):629-30. PubMed ID: 1898479 [No Abstract] [Full Text] [Related]
17. Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy? Adebayo D; Bjarnason I Postgrad Med J; 2006 Mar; 82(965):186-91. PubMed ID: 16517800 [TBL] [Abstract][Full Text] [Related]
18. [The NSAID gastropathy--a new hypothesis on the etiology]. Fredholm BB Lakartidningen; 1992 Jul; 89(28-29):2421-2. PubMed ID: 1507955 [No Abstract] [Full Text] [Related]
19. Cytoprotection in NSAID gastropathy. Roth SH Compr Ther; 1988 Feb; 14(2):3-5. PubMed ID: 3278837 [No Abstract] [Full Text] [Related]
20. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs]. Steen KS; Lems WF; Dijkmans BA Ned Tijdschr Geneeskd; 1999 Aug; 143(32):1649-52. PubMed ID: 10494299 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]